The store will not work correctly when cookies are disabled.
5-(2-(Aminomethyl)benzo[b]thiophen-6-yl)-N-phenylpicolinamide
ID: ALA4525480
PubChem CID: 134340380
Max Phase: Preclinical
Molecular Formula: C21H17N3OS
Molecular Weight: 359.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: NCc1cc2ccc(-c3ccc(C(=O)Nc4ccccc4)nc3)cc2s1
Standard InChI: InChI=1S/C21H17N3OS/c22-12-18-10-15-7-6-14(11-20(15)26-18)16-8-9-19(23-13-16)21(25)24-17-4-2-1-3-5-17/h1-11,13H,12,22H2,(H,24,25)
Standard InChI Key: OMIKJKNVZDVCKS-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
23.2504 -9.2256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6671 -9.9423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4254 -9.2256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9547 -9.8881 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.1546 -9.6381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4379 -10.0548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7214 -9.6381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7214 -8.8131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4379 -8.3965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1546 -8.8131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9547 -8.5631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0062 -10.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2973 -9.6329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5826 -10.0437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5809 -10.8695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2998 -11.2830 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0114 -10.8699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8665 -11.2819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1543 -10.8636 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8589 -12.1068 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4366 -11.2705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7290 -10.8519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0117 -11.2580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0047 -12.0838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7209 -12.5019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4351 -12.0934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
4 3 1 0
4 5 1 0
6 5 1 0
7 6 2 0
8 7 1 0
9 8 2 0
10 9 1 0
10 5 2 0
11 10 1 0
3 11 2 0
7 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
15 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 359.45 | Molecular Weight (Monoisotopic): 359.1092 | AlogP: 4.67 | #Rotatable Bonds: 4 |
Polar Surface Area: 68.01 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.57 | CX LogP: 4.01 | CX LogD: 2.82 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.56 | Np Likeness Score: -1.37 |
References
1. (2018) Lysyl oxidase-like 2 inhibitors and uses thereof, |